CA Stock MarketDetailed Quotes

BCT BriaCell Therapeutics Corp

Watchlist
  • 1.410
  • 0.0000.00%
15min DelayTrading Jul 5 16:00 ET
25.78MMarket Cap-2764P/E (TTM)

BriaCell Therapeutics Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
(Q1)Oct 31, 2022
(FY)Jul 31, 2022
(Q4)Jul 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-96.68%935.69K
-81.36%6.24M
-63.56%13.65M
-48.22%21.25M
-48.22%21.25M
-36.74%28.17M
-30.18%33.5M
-32.51%37.45M
-28.33%41.04M
-28.33%41.04M
-Cash and cash equivalents
-96.68%935.69K
-81.36%6.24M
-63.56%13.65M
-48.22%21.25M
-48.22%21.25M
-36.74%28.17M
-30.18%33.5M
-32.51%37.45M
-28.33%41.04M
-28.33%41.04M
-Accounts receivable
2.26%15.23K
237.65%30.15K
-27.91%21.41K
-21.70%18.87K
-21.70%18.87K
2.50%14.9K
-67.14%8.93K
53.64%29.7K
91.69%24.1K
91.69%24.1K
Total current assets
-81.26%5.53M
-65.40%11.74M
-51.84%18.41M
-36.36%26.95M
-36.36%26.95M
-36.18%29.5M
-29.76%33.94M
-31.64%38.22M
-26.73%42.35M
-26.73%42.35M
Non current assets
Investment properties
----
--281.66K
----
----
----
----
----
----
----
----
-Including:Available-for-sale securities
----
--281.66K
----
----
----
----
----
----
----
----
-Goodwill
-6.98%203.61K
-6.86%207.43K
-6.74%211.25K
-6.63%215.07K
-6.63%215.07K
-6.52%218.89K
-6.42%222.7K
-6.32%226.52K
-6.22%230.34K
-6.22%230.34K
-Other intangible assets
--8.81M
--8.42M
----
----
----
----
----
----
----
----
Regulatory assets
2.26%15.23K
237.65%30.15K
-27.91%21.41K
-21.70%18.87K
-21.70%18.87K
2.50%14.9K
-67.14%8.93K
53.64%29.7K
91.69%24.1K
91.69%24.1K
Liabilities
Current liabilities
-accounts payable
545.30%6.42M
537.21%3.71M
-45.20%433.92K
142.56%1.12M
142.56%1.12M
--995.25K
--582.45K
--791.75K
116.37%463.28K
116.37%463.28K
-Total tax payable
-83.41%5.68M
-52.19%16.62M
-44.53%15.06M
-6.92%29.14M
-6.92%29.14M
12,195.84%34.23M
13,893.32%34.77M
8,046.13%27.14M
5.00%31.31M
5.00%31.31M
Current accrued expenses
-13.53%335.36K
142.00%212.87K
236.03%612.59K
41.84%677.72K
41.84%677.72K
--387.84K
--87.96K
--182.3K
82.57%477.81K
82.57%477.81K
Current liabilities
388.60%6.76M
485.36%3.92M
7.44%1.05M
91.42%1.8M
91.42%1.8M
277.59%1.38M
10.78%670.41K
125.81%974.05K
69.02%941.09K
69.02%941.09K
Non current liabilities
Derivative product liabilities
-83.41%5.68M
-52.19%16.62M
-44.53%15.06M
-6.92%29.14M
-6.92%29.14M
12,195.84%34.23M
13,893.32%34.77M
8,763.43%27.14M
5.09%31.31M
5.09%31.31M
Total non current liabilities
-65.08%12.44M
-42.02%20.55M
-42.73%16.1M
-4.05%30.94M
-4.05%30.94M
5,424.26%35.61M
4,051.87%35.44M
3,577.44%28.12M
6.18%32.25M
6.18%32.25M
Shareholders'equity
Share capital
6.10%69.59M
6.10%69.59M
6.10%69.59M
6.10%69.59M
6.10%69.59M
17.44%65.59M
21.60%65.59M
18.48%65.59M
19.74%65.59M
19.74%65.59M
-common stock
6.10%69.59M
6.10%69.59M
6.10%69.59M
6.10%69.59M
6.10%69.59M
17.44%65.59M
21.60%65.59M
18.48%65.59M
19.74%65.59M
19.74%65.59M
Additional paid-in capital
----
----
24.90%7.92M
41.96%7.42M
41.96%7.42M
--6.89M
--6.61M
--6.34M
140.03%5.23M
140.03%5.23M
Gains losses not affecting retained earnings
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
Noncontrolling interests
--469.66K
----
----
----
----
----
----
----
----
----
Total equity
-79.13%6.2M
-64.20%12.23M
-51.58%18.62M
-36.20%27.16M
-36.20%27.16M
-36.03%29.72M
-29.64%34.16M
-31.53%38.45M
-26.65%42.58M
-26.65%42.58M
(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023(Q2)Jan 31, 2023(Q1)Oct 31, 2022(FY)Jul 31, 2022(Q4)Jul 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -96.68%935.69K-81.36%6.24M-63.56%13.65M-48.22%21.25M-48.22%21.25M-36.74%28.17M-30.18%33.5M-32.51%37.45M-28.33%41.04M-28.33%41.04M
-Cash and cash equivalents -96.68%935.69K-81.36%6.24M-63.56%13.65M-48.22%21.25M-48.22%21.25M-36.74%28.17M-30.18%33.5M-32.51%37.45M-28.33%41.04M-28.33%41.04M
-Accounts receivable 2.26%15.23K237.65%30.15K-27.91%21.41K-21.70%18.87K-21.70%18.87K2.50%14.9K-67.14%8.93K53.64%29.7K91.69%24.1K91.69%24.1K
Total current assets -81.26%5.53M-65.40%11.74M-51.84%18.41M-36.36%26.95M-36.36%26.95M-36.18%29.5M-29.76%33.94M-31.64%38.22M-26.73%42.35M-26.73%42.35M
Non current assets
Investment properties ------281.66K--------------------------------
-Including:Available-for-sale securities ------281.66K--------------------------------
-Goodwill -6.98%203.61K-6.86%207.43K-6.74%211.25K-6.63%215.07K-6.63%215.07K-6.52%218.89K-6.42%222.7K-6.32%226.52K-6.22%230.34K-6.22%230.34K
-Other intangible assets --8.81M--8.42M--------------------------------
Regulatory assets 2.26%15.23K237.65%30.15K-27.91%21.41K-21.70%18.87K-21.70%18.87K2.50%14.9K-67.14%8.93K53.64%29.7K91.69%24.1K91.69%24.1K
Liabilities
Current liabilities
-accounts payable 545.30%6.42M537.21%3.71M-45.20%433.92K142.56%1.12M142.56%1.12M--995.25K--582.45K--791.75K116.37%463.28K116.37%463.28K
-Total tax payable -83.41%5.68M-52.19%16.62M-44.53%15.06M-6.92%29.14M-6.92%29.14M12,195.84%34.23M13,893.32%34.77M8,046.13%27.14M5.00%31.31M5.00%31.31M
Current accrued expenses -13.53%335.36K142.00%212.87K236.03%612.59K41.84%677.72K41.84%677.72K--387.84K--87.96K--182.3K82.57%477.81K82.57%477.81K
Current liabilities 388.60%6.76M485.36%3.92M7.44%1.05M91.42%1.8M91.42%1.8M277.59%1.38M10.78%670.41K125.81%974.05K69.02%941.09K69.02%941.09K
Non current liabilities
Derivative product liabilities -83.41%5.68M-52.19%16.62M-44.53%15.06M-6.92%29.14M-6.92%29.14M12,195.84%34.23M13,893.32%34.77M8,763.43%27.14M5.09%31.31M5.09%31.31M
Total non current liabilities -65.08%12.44M-42.02%20.55M-42.73%16.1M-4.05%30.94M-4.05%30.94M5,424.26%35.61M4,051.87%35.44M3,577.44%28.12M6.18%32.25M6.18%32.25M
Shareholders'equity
Share capital 6.10%69.59M6.10%69.59M6.10%69.59M6.10%69.59M6.10%69.59M17.44%65.59M21.60%65.59M18.48%65.59M19.74%65.59M19.74%65.59M
-common stock 6.10%69.59M6.10%69.59M6.10%69.59M6.10%69.59M6.10%69.59M17.44%65.59M21.60%65.59M18.48%65.59M19.74%65.59M19.74%65.59M
Additional paid-in capital --------24.90%7.92M41.96%7.42M41.96%7.42M--6.89M--6.61M--6.34M140.03%5.23M140.03%5.23M
Gains losses not affecting retained earnings 0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K
Noncontrolling interests --469.66K------------------------------------
Total equity -79.13%6.2M-64.20%12.23M-51.58%18.62M-36.20%27.16M-36.20%27.16M-36.03%29.72M-29.64%34.16M-31.53%38.45M-26.65%42.58M-26.65%42.58M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg